The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

232

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2008

Study Completion Date

May 31, 2009

Conditions

Alzheimer's Disease

Interventions

DRUG

Galantamine CR

24 mg/day with dose-titration over twelve weeks

DRUG

Memantine

memantine 10 mg b.i.d. with a dose titration of sixteen weeks

DRUG

Placebo

Placebo will be similar in appearance to Memantine

All Listed Sponsors

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

lead

Charite University, Berlin, Germany

OTHER

NCT01921972 - The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease | Biotech Hunter | Biotech Hunter